On the day after admission, warfarin sodium 5 mg daily was initiated; enoxaparin was continued. Approximately 36 hours after admission, the patient became acutely hypotensive and developed ...
It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT) with or without pulmonary embolism (PE) when administered in conjunction with warfarin sodium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback